Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Nature Genetics|November 26, 2002
High frequency of BRAF mutations in neviPamela M Pollock, Ursula L Harper, Katherine S Hansen, et al.
Gynecologic Oncology|March 19, 2017
FGFR2 mutations are associated with poor outcomes in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group studyYvette W Jeske, Shamshad Ali, Sara A Byron, et al.
Communications Biology|August 31, 2021
A humanized orthotopic tumor microenvironment alters the bone metastatic tropism of prostate cancer cellsJacqui A McGovern, Nathalie Bock, Abbas Shafiee, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 30, 2018
Refinement of high-risk endometrial cancer classification using DNA damage response biomarkers: a TransPORTEC initiativeAurélie Auguste, Catherine Genestie, Marco De Bruyn, et al.
Ebiomedicine|August 20, 2015
The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression AnalysisMitchell S Stark, Kerenaftali Klein, Benjamin Weide, et al.
Cancer Research|June 25, 2009
Active Notch1 confers a transformed phenotype to primary human melanocytesChelsea C Pinnix, John T Lee, Zhao-Jun Liu, et al.
Oncogene|March 30, 2004
Microarray expression profiling in melanoma reveals a BRAF mutation signatureSandra Pavey, Peter Johansson, Leisl Packer, et al.
Molecular Cancer Research : MCR|January 17, 2009
Loss-of-function fibroblast growth factor receptor-2 mutations in melanomaMichael G Gartside, Huaibin Chen, Omar A Ibrahimi, et al.
Theranostics|February 28, 2020
Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancerBrittney S Harrington, Yaowu He, Tashbib Khan, et al.
Genome Medicine|January 11, 2022
Patient-derived xenograft models capture genomic heterogeneity in endometrial cancerVanessa F Bonazzi, Olga Kondrashova, Deborah Smith, et al.
Pageof 6